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Abstract
The first stem cells considered for the reconstruction of bone were bone marrow mesenchymal
stem cells (BMSCs). Subsequently, cells with similar marker expression panel and differentiation
potential were found in new sources of cells, such as adipose tissue. This source of stem cells has
a promising future in tissue-engineering applications, considering the abundance of this tissue in
the human body, the easy harvesting and the high number of stem cells that are available from
such a small amount of tissue. The isolation of the adipose stem cells is generally performed by
means of enzymatic digestion of the tissues, followed by a natural selection of the stem cells based
on their capacity to adhere to the culture flasks, leading to a quite heterogeneous population. This
constitutes a major drawback for the use of these cells, since the heterogeneity of the cell culture
obtained can compromise their proliferation and differentiation potential. In the present study we
have analysed the in vitro and in vivo behaviour of two selected subpopulations with high osteogenic
potential. For this purpose, ASCsCD29+ and ASCsSTRO−1+ subpopulations were isolated and in vitro
cultured onto a biodegradable polymeric scaffold, using osteogenic medium, before implantation
in a nude mice model. The biodegradable polymeric scaffold used is a fibre-mesh structure based
on a blend of starch and polycaprolatone (SPCL) that has been successfully used in several bone
tissue-engineering studies. The implanted ASCs–scaffold constructs promoted the formation of new
bone tissue in nude mice. However, the results obtained show differences in the behaviour of the
two ASCs subpopulations under study, particularly regarding their potential to differentiate into the
osteogenic lineage, and allowed the indentification of ASCsSTRO−1+ as the best subpopulation for
bone tissue-engineering applications. Copyright  2011 John Wiley & Sons, Ltd.
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1. Introduction
Bone tissue engineering is that discipline of regenerative
medicine that involves the development of therapies
for the regeneration of skeletal tissue using cells and
a support material that promotes the adhesion, growth
and differentiation of cells, sometimes also with the help
of specific growth factors.
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The scaffold is a fundamental element of bone tissue-
engineering strategies, since it is very important to
provide bone precursor cells with an appropriate three-
dimensional (3D) support and adequate biomechanical
environment. Therefore, the materials selected for the
scaffold should allow higher control to be achieved
over parameters such as porosity, pore size, surface
area and the mechanical properties of the 3D support
(Silva et al., 2007), and simultaneously they should
be degradable and biocompatible (Gomes and Reis,
2004). Several studies (Gomes et al., 2001a, 2001b,
2003, 2006a, 2006b; Tuzakoglu et al., 2005, 2009) have
demonstrated that fibre-meshes obtained from a blend
of starch and polycaprolactone (SPCL) are an excellent
scaffolding material, that allows the proliferation and
osteogenic differentiation of stem cells and also the
adhesion and growth of endothelial cells, providing
evidence of their suitability to support the formation
of vascularized bone-like tissue (Fuchs et al., 2009a,
2009b; Santos et al., 2007, 2008). SPCL-based materials
were therefore the scaffolds selected for the present
study.
In bone tissue-engineering applications, the adult stem
cells that have been most widely used are mesenchymal
stem cells (MSCs). The first and most well-known source
of MSCs is the bone marrow. Lately, several research
studies (Yoshimura et al., 2007; Gay et al., 2007; Hennrick
et al., 2007; Hui et al., 2005; Majore et al., 2009) have
shown that MSCs can be isolated from other sources,
such as adipose tissue. Although the discovery of the
adipose tissue as source of stem cells is relatively recent
(Zuk et al., 2001), the high potential of these stem cells
for tissue-engineering applications and other cell-based
therapies is very well supported by the simplicity of
the procedures to harvest adipose tissue, which causes
minimal discomfort for patients while allowing large
amounts of tissue to be obtained, from which it is possible
to isolate a large quantity of stem cells. Furthermore,
adipose stem cells (ASCs) can be differentiated into a
large number of cell types, such as chondrocytes and
osteoblasts (Xu et al., 2005; Ogawa et al., 2004; Zuk et al.,
2002; Huang et al., 2005;Mochizuki et al., 2006), neuron-
like cells (Zuk et al., 2001; Safford et al., 2002; Fujimura
et al., 2005), myocytes (Lee and Kemp, 2006; Fraser
et al., 2006; Strem et al., 2005; Planat-Bernard et al.,
2004), hepatocytes (Yamamoto et al., 2008; Stock et al.,
2008) and, of course, adipocytes (Rada et al., 2009a;
Gimble and Guilak, 2003a, 2003b). Additionally, the ASCs
have a low immunological reactivity, as demonstrated by
recent studies where, in fact, the ASCs were found to be
negative regarding the expression of the most important
immunologically relevant surface antigens, such as MHC-
II, CD40, CD40L, CD80 and CD86. These cells also
do not express IL-10 and TGFβ, well-known inhibitor
factors of lymphocytes (Puissant et al., 2005) and this
lack of expression is also maintained after osteogenic
differentiation (McIntosh et al., 2006). ASCs are also
unable to incite a response of allogenic lymphocytes
in vitro, inhibiting allogenic lymphocyte proliferation
induced by allogenic PBMCs or mitogens (McIntosh
et al., 2006), and this phenomenon is proportional to
the number of ASCs and to the time of contact between
stem cells and lymphocytes (Rada et al., 2009a; Puissant
et al., 2005).
In previous studies (Rada et al., 2009b, 2010) we
have isolated ASC subpopulations (from rat and human
origin) using immunomagnetic beads coated with a
range of antibody (ab) markers for these stem cells,
viz. CD29, CD105, CD90, p75, STRO-1, CD44, CD73
and CD49d. From the results obtained in these studies,
it was possible to select two subpopulations with high
osteogenic potential, viz. the subpopulations isolated
using immunomagnetic beads coated with anti STRO-1
ab and CD29 ab.
Although in previous studies our group was able
to select ASC subpopulations with good osteogenic
differentiation potential, all the experiments were carried
out in vitro; obviously between an in vitro and an in vivo
system there are several differences that could affect
the behaviour and the differentiation potential of the
cells. Since the final aim of the studies including cells
and scaffolds is an application in vivo, the main aim
of this study was to assess the potential of these
two cell subpopulations in vivo and eventually select
the most adequate hASCs subpopulation to use in
bone tissue-engineering strategies. For this purpose,
the selected hASCs subpopulations were seeded onto
starch–polycaprolactone (SPCL) fibre-mesh scaffold, a
scaffold that has been well studied by our research
group (Gomes et al., 2003, 2006b, 2008; Tuzakoglu
et al., 2009; Fuchs et al., 2009a; Santos et al., 2007;
Oliviera et al., 2007; da Silva et al., 2009; Martins
et al., 2008, 2009; Silva et al., 2009). The cells used
were transfected with green fluorescent protein (GFP)
to assess their presence in the scaffold for the whole
time of the experiments. The cell–scaffold constructs
were cultured in vitro for 1 day with osteogenic medium
and then implanted in an ectopic site (subcutaneous) in
nude mice. The constructs were retrieved 6 weeks after
implantation and analysed by RT–PCR and histologically,
as well as by micro-computerized tomography (µCT), to
assess hASCs differentiation and subsequent new bone
formation.
2. Materials and methods
2.1. Scaffold preparation
Scaffolds based on SPCL (a 30:70 wt% blend of starch
with poly-caprolactone) were prepared by a fibre-bonding
process consisting of cutting and sinteringmelt-spun fibres
with a diameter of approximately 180 µm, as described
previously (Gomes et al., 2006b; Santos et al., 2008;
Martins et al., 2008). All samples were then cut into
discs of approximately 6 mm diameter and 1.5–2 mm
height and sterilized using ethylene oxide. In the SPCL
fibre-meshes obtained by this method the porosity of the
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scaffolds was 75% and highly interconnected (Gomes
et al., 2003).
2.2. Adipose tissue digestion and cell
harvesting
Human subcutaneous adipose tissue samples were
obtained from lipoaspiration procedures performed in
women within an age range of 35–45 years, under
a previously approved protocol with a local hospital
(Hospital da Prelada, Porto, Portugal).
The tissue was first washed with phosphate-buffered
saline (PBS; Sigma-Aldrich, Germany) containing 5 mg/
500 ml Ciprobay 200 (Bayer) and 10% Antibiotic–
Antimycotic (Gibco, UK) and then digested with a 0.2%
collagenase type I A (Sigma-Aldrich) solution in PBS for
60 min at 37 ◦C under gentle stirring. The digested tissue
was filtered using a 100 µm filter mesh (Sigma-Aldrich),
centrifuged at 1250 rpm for 7 min at 20 ◦C and then the
supernatant was eliminated. The cell pellet obtained was
resuspended and further submitted to a procedure for
isolating cell subpopulations, as described in the next
section.
2.3. Isolation of hASC subpopulations
For this study we selected two subpopulations isolated by
a method based on the use of immunomagnetic beads,
which has been described previously (Rada et al., 2009b).
The method consists of using immunomagnetic Dynal M-
450 Epoxy beads (Dynal Biotech, USA) that were coated
with either anti CD29 or STRO-1 antibody by preparing a
mixture at a concentration of 4 µg ab/1 × 107 Dynabeads.
The CD 29 and STRO-1 were selected within a range
of antibodies based on a previous study (Rada et al.,
2010), which showed that the cells isolated with these
two antibodies exhibit a high osteogenic differentiation
potential. The cell pellet obtained from the enzymatic
digestion of adipose tissue was resuspended in 0.1%
BSA (Sigma-Aldrich) in PBS and then mixed with the
Ab-coated Dynabeads. The mixture was incubated for
30 min at 4 ◦C under gentle stirring and subsequently
the cell suspension and beads mixture was washed with
PBS and BSA. Finally, the cells bonded to the Ab-
coated Dynabeads were separated from the remainder
of the cell suspension using the Dynal MPC magnet
(Dynal Biotech) and seeded in 25 cm2 cell culture
flasks.
2.4. Cell transfection of hASCs
The isolated hASCs subpopulations were transfected with
green fluorescent protein (GFP) in order to enable these
cells to be traced upon implantation and their role in
the formation of new tissue in vivo to be analysed. For
this purpose, after reaching confluence, the cell culture
medium was substituted by medium without antibiotic
and without serum. On the following day, lipofectamine
(Invitrogen, USA) and pDsGreen-N1 Vector (Clontech,
USA) were used to transfect the cells. Briefly, 8 µg
plasmid DNA was diluted in 0.5 ml DMEM medium
without FBS and 20 µl lipofectamine 2000 were diluted
in 0.5 ml DMEM serum-free medium. The two solutions
were then mixed together and added to cells in the
25 cm2 culture flasks containing 5 ml of DMEM without
antibiotic. The cells were exposed to the complex of
lipofectamine and plasmid (in an incubator at 37 ◦C and
5% CO2) for 4 h and then the medium was substituted
with DMEM containing 1% antibiotic (Sigma-Aldrich) and
10% FBS.
2.5. Cell seeding and culturing into SPCL
scaffolds
After transfection and further expansion for about
15 days, the CD29+ and STRO-1+ ASCs populations
were trypsinized, counted and seeded/cultured in SPCL
fibre-mesh scaffolds. The scaffolds were press-fitted into
cassettes for a higher cell-seeding efficiency, and placed
in six-well plates; then 300 µl of a diluted cell suspension
containing 5 × 106 cells was seeded onto the surface
of each scaffold. The well plate was then transferred
to the incubator for 3 h and afterwards 1.5 ml DMEM
was added to each well containing the cassette with
the cell-seeded scaffold. After 12 h of incubation, the
scaffolds were gently removed from the cassettes and
transferred into new six-well plates, adding 1 ml basal
medium. Each ASC subpopulation was seeded in 14
scaffolds: eight to be implanted in nude mice and six that
were used as in vitro controls. The two subpopulations
of ASCs were also seeded in six-well plates and kept
in culture for the same period of the in vitro/in vivo
experiment.
After 1 day of culture, the culture mediumwas replaced
by osteogenic medium composed of α-modified Eagle’s
medium (Sigma-Aldrich) supplemented with 50 µg/ml
ascorbic acid (Sigma-Aldrich), 10−8 M dexamethasone
(Sigma-Aldrich), 10 mM β-glycerol phosphate (Sigma-
Aldrich), 10%FBS (Gibco) and 1%Antibiotic/Antimycotic
(Gibco). The cell-seeded scaffolds were cultured with
osteogenic medium for 2 weeks, except one group of the
in vitro control which was cultured with basal medium
through the whole experiment.
2.6. In vivo implantation of the cell scaffold
construct
For the in vivo experiments, six female nude mice aged
4 weeks (Harlan Laboratories, USA) were used. Each test
animal was anaesthetized with a subcutaneous injection
of 0.5 mg/kg medetomidine hydrochloride and 75 mg/kg
ketamine hydrochloride. Under sterile conditions (ver-
tical laminar flow chamber), the skin was disinfected
and two medial and ventral incisions (approximately
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1 cm) were performed in the dorsum of each mouse,
containing the subcutis and the panniculus carnosus
(skin smooth muscle). Craniolaterally orientated pock-
ets (two per incision) were subcutaneously created by
blunt dissection. The scaffolds (four samples/animal)
were inserted into these pockets The panniculus carnosus
and the skin were carefully sutured and the wounds
desinfected. The animals were kept with food and
water ad libitum during the whole time of implanta-
tion.
At the end point of the experiment (6 weeks), the ani-
mals were sacrificed by cervical dislocation. The implants
and respective surrounding tissue were explanted and
processed for histological evaluation and molecular biol-
ogy analysis by real-time reverse transcriptase polymerase
chain reaction (RT–PCR) and µCT, as described in further
sections.
2.7. RT–PCR
The mRNA of each sample was extracted with TriZol
reagent (Invitrogen), following the procedure provided
by the supplier. Briefly, 800 µl TriZol was added for each
sample. After an incubation of 5 min, an additional 160 µl
of chloroform (Sigma-Aldrich) was added; the samples
were then incubated for 15 min at 4 ◦C and centrifuged at
the same temperature and 13 000 rpm for 15 min. After
the centrifugation, the aqueous part was collected and
an equal part of isopropanol (Sigma-Aldrich) was added.
After an incubation of 2 h at −20 ◦C the samples were
washed in ethanol, centrifuged at 4 ◦C and 9000 rpm
for 5 min and resuspended in 12 µl RNase/DNase-free
water (Gibco). The samples were quantified using a ND-
1000 Spectrophotometer (NanoDrop Technologies, USA).
The samples selected for the cDNa synthesis were those
presenting a 260:280 ratio in the range 1.7–2.0. The
cDNA synthesis was performed using the iScript cDNA
synthesis Kit (BioRad, USA), and the MiniOpticom real-
time PCR Detection System (BioRad), using an initial
amount of 2 µg mRNA and a total volume of 20 µl.
RNAse-free water (Gibco) was used as the negative
control.
2.8. Real-time PCR
The expression of RunX-2, Osterix, Osteopontin and
Osteocalcin was assessed on each sample after the mRNA
extraction and the RT–PCR synthesis as described above
for the synthesis of the cDNA.
For each sample, GAPDH was used as housekeeping
gene. The primers were previously designed using Primer
3 software (v. 0.4.0) and synthesized by MWG Biotech
(Germany).
The real-time PCR was carried out using iQ Syber Green
SuperMix equipment (BioRad, USA). The procedure
followed to perform the reactions was based on the
manufacturer’s instructions. The data obtained was
normalized using the Ct method. The results obtained
were elaborated using Origin Pro 7.0 software (OriginLab
Corp., USA) and the correlation between the dataset
from the same gene analysed was investigated using the
single-factor ANOVA method.
2.9. Histological analysis
The samples harvested from the in vivo and in vitro
experiments were fixed in formalin, paraffin embedded
and then sectioned at 4 µm thickness using a Microm
HM 355S microtome (Thermo Scientific, USA). Sample
sections were floated in a water bath at 40 ◦C, placed on
microscope slides, dewaxed in xylenes and rehydrated in
an ethanol bath and then stained or immunostained as
follows:
• Alizarin red staining. Sections were stained with
a 2% alizarin red solution (Merck, Germany) in
distilled water for 5 min, and finally washed with
distilled water.
• Xylenol orange staining. Sections were stained for
5 min with a solution previously prepared by
dissolving powder stain in distilled water and the
pH was adjusted to 7.2–7.4 using HCl.
• Immunohistological analysis. For the immunohisto-
logical analysis (collagen I and osteopontin) the
Vectastain ABC Kit (Vector Laboratories, USA) was
used. The sample sections were washed with dis-
tilled water and then incubated for 30 min in
0.3% H2O2–methanol solution to quench endoge-
nous peroxidase activity. After this step, the slides
were washed with PBS for 5 min and after-
wards incubated for 30 min with diluted normal
serum. Then the sections were washed again
and incubated for 30 min at room temperature
with the primary antibody under analysis, viz.
anti-collagen I antibody (Santa Cruz Biotechnolo-
gies, USA) and anti-osteopontin antibody (AbCam,
USA). After this incubation period the sections
were incubated for 30 min at room temperature
with diluted biotinylated secondary antibody solu-
tion. Finally the sections were coloured using
the DAB substrate Kit (Vector Laboratories, USA).
To observe the localization of hASC implanted
cells (transfected with GFP), further sections were
observed under a fluorescence microscope within
12 h after the collection of the implants from the
mice.
• Microscopical analysis. All stained/immunostained
samples were observed under an Imager. Z1 flu-
orescence microscope (Zeiss, Germany) and pho-
tographed using an Axio Cam MRm (Zeiss).
2.10. Micro-computerized tomography (µCT)
analysis
The formation of mineralized tissue in the explants was
evaluated using a high-resolution µCT Skyscan 1072
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Figure 1. Graphic representation of the results obtained from real-time RT–PCR analysis of runx-2, osterix (OSX), osteopontin (OP)
and osteocalcin (OC) obtained in the constructs seeded/cultured with the two hASCs populations considered and either implanted or
in vitro cultured under different conditions. (A) ASCsCD29+ seeded in SPCL scaffolds and cultured in vitro with osteogenic medium;
(B) ASCsCD29+ seeded in SPCL scaffolds and implanted in nude mice; (C) ASCsSTRO−1+ seeded in SPCL scaffolds and cultured in vitro
with osteogenic medium; (D) ASCsSTRO−1+ seeded in SPCL scaffolds and implanted in nude mice
scanner (Skyscan, Kontich, Belgium). Each sample was
scanned in high-resolution mode with a pixel size of
8.7 µm and an exposure time of 1.8 ms. The X-ray source
was set at 51 keV of energy and 169 µA of current.
Approximately 400 projections were acquired over a
rotation of 180◦ with a rotation step of 0.45◦. Each one
of these projections was segmented into binary images
with a dynamic threshold of 220–255 (grey values) to
assess new bone formation. These datasets were used for
morphometric analysis (CT Analyser, v. 1.5.1.5, SkyScan)
and to built 3D models (ANT 3D creator, v2.4, SkyScan).
The distribution and quantification of new bone formation
in the scaffolds was assessed by a 3D virtual model
that was created, visualized and registered using both
image processing softwares (CT Analyser and ANT 3D
creator).
2.11. Statistical analysis
Data obtained from real-time RT–PCR analysis are
presented as arithmetic means ± SD. An ANOVA single-
factor test was used to compare the mean values and
differences were considered to be statistically significant
at p < 0.05. All statistical analyses were performed using
Origin Pro 7.0 software (OriginLab Corp., USA).
3. Results
3.1. ASCs gene expression
Real-time RT–PCR was used to analyse the expression of
runx-2, osterix, osteopontin and osteocalcin in the samples
retrieved from the in vivo implantation and from the
in vitro cultures carried out.
The results obtained from real-time RT–PCR analyses
are represented in the graphics presented in Figure 1. In
general, these results showed that in all the conditions
studied, the expression of the osteogenic markers consid-
ered is observed. However, in the cell–scaffolds cultured
in vitro, the gene expression levels differ significantly
with respect to the cells that were implanted in the nude
mice. In fact, concerning ASCCD29+, the expression of
osteopontin is much higher in implanted cells than in the
cells cultured in vitro, while concerning runx-2 expression
the opposite behaviour was observed. For the ASCCD29+
subpopulation, the expression of the other genes con-
sidered is not considerably different in the in vivo as
compared to the in vitro samples. On the other hand,
in samples corresponding to the ASCSTRO−1+ subpopula-
tion, all the genes considered are overexpressed in the
samples retrieved from nude mice compared with those
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Figure 2. Fluorescent microscope images of the constructs seeded/cultures with the two hASCs populations considered transfected
with GFP and either implanted or in vitro cultured under different conditions. (A) ASCsCD29+ seeded in SPCL scaffolds and
implanted in nude mice; (B) ASCsSTRO−1+ seeded in SPCL scaffolds and implanted in nude mice; (C) ASCsCD29+ seeded in SPCL
scaffolds and cultured in vitro with basal medium; (D) ASCsSTRO−1+ seeded in SPCL scaffolds and cultured in vitro with basal
medium; (E) ASCsCD29+ seeded in SPCL scaffolds and cultured in vitro with osteogenic medium; (F) ASCsSTRO−1+ seeded in SPCL
scaffolds and cultured in vitro with osteogenic medium
cultured in vitro. Most importantly, real-time RT–PCR
results clearly showed that the ASCSTRO−1+ population
exhibited a gene expression of all the osteogenic markers
analysed higher than the ASCCD29+ population.
3.2. Localization of hASCs – green fluorescent
protein detection
The samples retrieved from the in vivo experiment and
those cultured in vitro during the same time period
(with either basal medium or with osteogenic medium)
were observed under a fluorescence microscope, aim-
ing to detect the ASCs producing GFP and therefore to
relate the presence (or not) of cells that were originally
seeded/implanted to the functionality of the cell-scaffold
constructs. In all the ASCs–scaffold samples considered,
containing either ASCCD29, or ASCSTRO−1+ and implanted
or cultured in vitro, it was possible to detect cells that
were initially seeded into the scaffolds (Figure 2). The
presence of the transfected cells within the scaffolds that
are implanted in vivo demonstrate that most of the cells
did not migrate during the 6 weeks of the in vivo implan-
tation and that all the results obtained are related to the
human ASCs that were originally implanted.
3.3. Alizarin red and xylenol orange staining
After the 6 weeks of implantation/in vitro culture, all
the samples were positively stained with alizarin red,
as shown in Figure 3, indicating the occurrence of a
mineralization process. In all the study groups it was
also possible to visualize positive staining with xylenol
orange, showing the occurrence of mineralization in all
cell–scaffold constructs considered (Figure 4). However,
the samples that were implanted exhibited a higher
fluorescence, indicating a more extensive mineralization
than in constructs that were cultured in vitro for the same
period of time.
3.4. Immunohistological analysis
All samples retrieved after 6 weeks of implanta-
tion/in vitro culture were immunostained for collagen
I and osteopontin (Figures 5, 6). The results obtained are
in good agreement with those obtained from real-time
RT–PCR analysis: in the cell–scaffold constructs cultured
in vitro with basal medium, there are no signs of the pres-
ence of the markers assessed, suggesting that, under these
conditions, the ASCs did not differentiate into osteoblast-
like cells; in the cell–scaffold constructs in vitro cultured
with osteogenic medium, a light coloration was observed,
indicating that the process of osteogenic differentiation
might be ongoing; finally, the hASC–scaffold constructs
retrieved from the in vivo implantation showed strong
positive staining regarding both osteogenic markers con-
sidered in the immunohistological assay.
3.5. Micro-computerized tomography (µ-CT)
analysis
In Figure 7 it is possible to visualize two representative
images of ASCSTRO−1+ – scaffold and ASCCD29+ – scaffold
constructs retrieved from the in vivo experiments and
analysed by µCT, that show very clearly that in constructs
with ASCsSTRO−1+ the mineralization is much more
evident than in constructs seeded with ASCsCD29+. The
presence of calcified tissue was detected not only on the
surface of the scaffold but also inside, this attesting to the
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Figure 3. Optical microscopy pictures showing slide sections of the constructs seeded/cultured with the two hASCs populations
considered and either implanted or in vitro cultured under different conditions and stained with alizarin red S. (A) ASCsCD29+
seeded in SPCL scaffolds implanted in nude mice (×100); (B) ASCsSTRO−1+ seeded in SPCL scaffolds implanted in nude mice (×100);
(C) ASCsCD29+ seeded in SPCL scaffolds cultured in vitro with osteogenic medium (×100); (D) ASCsSTRO−1+ seeded in SPCL scaffolds
cultured in vitro with osteogenic medium
homogeneous distribution of cells into the scaffolds and
their active metabolism and osteogenic differentiation
in the whole volume of the construct. Finally, the µCT
analysis further confirms the results obtained from real
time RT–PCR and from the histological analysis, i.e.
the higher osteogenic potential of constructs containing
hASCsSTRO−1+.
4. Discussion
The present study allowed comparison of two selected
hASC subpopulations previously studied (Rada et al.,
2010) and to clarify the behaviour of these cells, partic-
ularly their in vivo and in vitro osteogenic differentiation
potentials, when seeded into SPCL fibre-mesh scaffolds,
a well-characterized 3D structure (Gomes et al., 2003,
2008; Fuchs et al., 2009a; da Silva et al., 2009; Jukola
et al., 2008). In order to trace the eventual cell migra-
tion, the cells used for the experiments were transfected
with GFP. The detection of fluorescent cells in sections
obtained from different samples confirms that most of
the ASCs initially seeded in the scaffold were found in
the original site of implantation of the construct, which
allows direct correlation of the results obtained for the
constructs that were implanted in nude mice to human
ASCs and not to mouse stem cells that eventually could
have migrated into the implant site.
The histological stainings and immunohistochemistry
analyses showed that a mineralization process was
ongoing in all the groups of samples considered, although
the samples retrieved from nude mice showed a higher
coloration when stained with alizarin red and higher
fluorescence when stained with xylenol orange. Also
regarding the immunohistochemistry for collagen I and
osteopontin, it was possible to observe enhanced staining
in samples retrieved from in vitro cultures, as compared
to those that were implanted in nude mice. In fact, in
the ASCs cultured in SPCL scaffolds in vitro with basal
medium no posively stained regions were found, while
ASCs cultured in SPCL scaffolds in vitro with osteogenic
medium show some positive staining of the two osteogenic
markers considered.
The results obtained with histological assays were
confirmed by real-time RT–PCR. In fact the hASCsCD29+
scaffold constructs retrieved from the in vivo implants
show an higher osteopontin expression when compared
with the in vitro-cultured constructs containing the
same hASCs subpopulation, while all the expression
levels of the other genes considered is higher in
the hASCsCD29+ – scaffold constructs resulting from the
in vitro cultures. Regarding the constructs with the
hASCsSTRO−1+, it was possible to observe a completely
different scenario: in fact, all the osteogenic gene
markers considered were more highly expressed in the
constructs resulting from the implantation in nude mice
compared with those retrieved from in vitro cultures.
It is also important to highlight that the results
obtained showed that all the samples cultured in 3D,
i.e. all cells that were seeded/cultured onto the SPCL
fibre-mesh scaffolds, exhibited higher osteogenic gene
expression levels than cells cultured in 2D (well-plates;
data not shown), demonstrating the importance of an
adequate 3D environment in the development of the
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Figure 4. Optical microscopy pictures showing slide sections of the constructs seeded/cultured with the two hASCs populations
considered and either implanted or in vitro cultured under different conditions and stained for xylenol orange. (A) ASCsCD29+
seeded in SPCL scaffolds implanted in nude mice (×100); (B) ASCsSTRO−1+ seeded in SPCL scaffolds implanted in nude mice (×100);
(C) ASCsCD29+ seeded in SPCL scaffolds cultured in vitro with osteogenic medium (×100); (D) ASCsSTRO−1+ seeded in SPCL scaffolds
cultured in vitro with osteogenic medium
Figure 5. Optical microscopy pictures showing sections of the constructs seeded/cultured with the two hASCs populations
considered and either implanted or in vitro cultured under different conditions and immunostained for osteopontin. (A) ASCsCD29+
seeded in SPCL scaffolds implanted in nude mice (×100); (B) ASCsSTRO−1+ seeded in SPCL scaffolds implanted in nude mice (×100);
(C) ASCsCD29+ seeded in SPCL scaffolds cultured in vitro with osteogenic medium (×100); (D) ASCsSTRO−1+ seeded in SPCL scaffolds
cultured in vitro with osteogenic medium
osteoblastic differentiation process and subsequent new
bone formation.
Particularly interesting are the results obtained
for constructs implanted in vivo that were previously
seeded/cultured with the hASCsSTRO−1+ population,
when compared to constructs seeded/cultured with the
hASCsCD29+; in fact, ASCs isolated with immunomag-
netic beads coated with anti-STRO-1 antibody exhibited
a much higher gene expression than those isolated with
immunomagnetic beads coated with anti-CD29 antibody,
demonstrating that the hASCsSTRO−1+ population is in a
more advanced osteogenic differentiation stage than the
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Figure 6. Optical microscopy pictures showing sections of in the constructs seeded/cultured with the two hASCs populations
considered and either implanted or in vitro cultured under different conditions and immunostained for collagen I. (A) ASCsCD29+
seeded in SPCL scaffolds cultured in vitro with basal medium (×100); (B) ASCsSTRO−1+ seeded in SPCL scaffolds cultured in vitro
with basal medium (×100); (C) ASCsCD29+ seeded in SPCL scaffolds implanted in nude mice (×100); (D) ASCsSTRO−1+ seeded in
SPCL scaffolds implanted in nude mice (×100); (E) ASCsCD29+ seeded in SPCL scaffolds cultured in vitro with osteogenic medium
(×100); (F) ASCsSTRO−1+ seeded in SPCL scaffolds cultured in vitro with osteogenic medium
Figure 7. µCT 3D virtual models images of SPCL scaffolds
seeded with hASCs subpopulation and implanted in nude mice.
(A) Scaffolds seeded with ASCsCD29+; (B) scaffolds seeded with
ASCsSTRO
other ASCs population considered, data that were also
confirmed by the amount of mineralization detected by
µCT analysis.
Analysing the results obtained from the hASCsSTRO−1+
population implanted in vivo, is possible to see a
high expression of osterix, a gene that stimulates
osteogenic differentiation and prevents chondrogenic
differentiation (Caetano-Lopez et al., 2007) and that
is essential to reach the status of osteoprogenitor
cells (Ellies and Krumlauf, 2006; Stains and Civetelli,
2003). Contemporary to osterix, runx-2 is also highly
expressed; in the hASCsSTRO−1+ population implanted
in vivo, the expression of this osteogenic differentiation
gene is the highest of all the groups studied. Runx-
2 plays a critical role in osteogenic differentiation,
particularly at the beginning of this process, contributing
to the differentiation of mesenchymal stem cells to
osteoprogenitor cells as well as in the differentiation of
osteoprogenitor cells to osteoblasts (Ellies and Krumlauf,
2006; Stains and Civetelli, 2003; Karsenty, 2001).
Considering that, in the case of hASCsSTRO−1+, besides the
high levels of Runx-2, high expression of osteopontin and
especially osteocalcin has also been detected, suggesting
that the differentiation process is in the final stage and the
cells implanted are almost differentiated into osteoblasts.
The hASCsCD29+ population implanted in vivo presents
a different scenario regarding gene expression; in fact
the massive overexpression of osterix compared with the
other genes considered leads to the conclusion that these
cells may have reached the status of osteoprecursor but are
still not yet at that stage of differentiation that identifies
them as osteoblasts.
Finally, when the results of cells implanted in vivo are
compared with those cultured in vitro, it is possible to
report two important findings. First, the expression levels
of all genes studied obtained from in vivo and in vitro
culture are either similar to or lower in the in vitro
cultured constructs, underlining the role of an adequate
physiological context (the in vivo environment) in which
cells can sense several stimuli, not found in vitro, that
promote the overexpression of the genes involved in
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osteogenic differentiation. Considering the position of
the implants (subcutaneous) and the tissue surrounding
the scaffold–cell constructs (mostly highly vascularized
adipose tissue), most likely the factors stimulating the
differentiation are VEGF (Maes et al., 2004; Zeng et al.,
2007) and PPAR-γ or leptin (Gimble et al., 2006). Second,
the two ASC subpopulations considered, which were
selected based on their osteogenic potential assessed
in a previous in vitro study, showed different behaviour
in vitro and in vivo, i.e. hASCsSTRO−1+ clearly showed
higher osteogenic differentiation potential in vivo, while
hASCsCD29+ demonstrated a good osteogenic differentia-
tion potential in vitro, but not as good in vivo. The dif-
ferences found in the osteogenic differentiation potential
according to the cell subpopulation considered provides
further evidence of the limitations of in vitro models,
when the aim is to understand the behaviour of hASCs in
a physiological environment.
Overall, the results obtained from this study allowed
us to conclude that human adipose-derived stem cells
isolated using anti STRO-1 ab have a great osteogenic
potential and may enable a more efficient use of adipose
tissue as a cell source for bone tissue-engineering appli-
cations. The data showed also confirm the importance of
the physiological context and also of the 3D environment
provided by an adequate scaffold, specifically the SPCL
fibre-meshes, to enhance bone regeneration through TE
therapies. Despite the importance of the identification of a
subpopulation of ASCs with great potential for osteogenic
differentiation, further studies will be crucial to determine
the correlation between STRO-1 and osteogenic differen-
tiation and, globally, the role of STRO-1-positive stem
cells in the different niches of the human body.
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